Takeda Pharmaceutical Company Limited (TKPHF) は上場企業です ヘルスケア セクターの Drug Manufacturers - Specialty & Generic 業界で事業展開. 本社所在地は Tokyo, 日本. 現CEOは Christophe Weber.
TKPHF を有する IPO日 2008-06-25, 49,281 名の正社員, に上場 Other OTC, 時価総額 $54.53B.
Takeda Pharmaceutical Company Limited is a global pharmaceutical company headquartered in Tokyo, Japan, with operations across Japan, the United States, Europe, and other international markets. Founded in 1781, the company engages in the research, development, manufacture, and marketing of pharmaceutical products across five core therapeutic areas: gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Takeda markets numerous branded pharmaceutical products including Entyvio, Velcade, Adcetris, and Takhzyro, among others, and maintains an extensive network of collaborations, licensing agreements, and strategic alliances with leading research institutions and biotechnology companies worldwide to support its innovation pipeline.
